Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 1 1 0
2515 2515 2515 2 25 251 2515 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 0 no 0 10 0 0 0 0 0
-Hematopoiesis -Hematopoiesis -hematopoiesis - -H -He -Hem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 10 0 0 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 0 0 0 0
Outcome of outcome O Ou Out Outc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 10 0 1 0 0 1
a report a a a a a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Francesco Pegoraro, francesco F Fr Fra Fran BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,,,,,, 7 10 0 1 0 0 1
Trambusti, 2,5 trambusti, T Tr Tra Tram BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,,,, 6 10 1 1 0 0 1
Stefania Gaspari, stefania S St Ste Stef BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 ,',,,, 6 10 1 1 0 0 1
Claudio Favre, claudio C Cl Cla Clau BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 ,, 2 10 1 1 0 0 1
Histiocytosis Working histiocytosis H Hi His Hist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 # 1 10 1 1 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
Department of department D De Dep Depa BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,; 3 10 1 0 0 0 1
Oncology, Meyer oncology, O On Onc Onco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,',;, 5 10 1 0 0 0 1
Psychology, Drug psychology, P Ps Psy Psyc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,(),, 5 10 1 0 0 0 1
Florence; 4 florence; F Fl Flo Flor BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ;"", 4 10 1 0 0 0 1
University of university U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,;, 3 10 1 0 0 0 1
University of university U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,;,-, 5 10 1 0 0 0 1
Hospital, Naples; hospital, H Ho Hos Hosp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 ,;,,; 5 10 1 0 0 0 1
8 8 8 8 8 8 8 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 3 no 0 10 1 0 0 0 1
Pediatric Hematology pediatric P Pe Ped Pedi BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 ,,.. 4 10 1 0 0 0 1
Città della città C Ci Cit Citt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 -,; 3 10 1 0 0 0 1
Hematology Oncology, hematology H He Hem Hema BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 ,, 2 10 0 0 0 0 1
Integrata, Verona; integrata, I In Int Inte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ,;,, 4 10 0 0 0 0 1
Gesù Children's gesù G Ge Ges Gesù BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ',,;,, 6 10 0 0 0 0 1
University of university U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 -,;,, 5 10 0 0 0 0 1
Padua; 13 padua; P Pa Pad Padu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ;,,,. 5 10 0 0 0 0 1
Hospital, Azienda hospital, H Ho Hos Hosp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,,, 3 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 5 # 1 10 0 0 0 0 1
An appendix an A An An An BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
at the at a at at at BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 10 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
Primary hemophagocytic primary P Pr Pri Prim BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 (),- 4 9 0 0 0 0 1
defects in defects d de def defe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -. 2 9 0 0 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 . 1 9 0 0 0 0 1
age at age a ag age age BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 (,-),()-.- 10 9 0 0 0 0 1
tients who tients t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -(-,-,-),() 11 8 0 0 0 0 1
response and response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ().,(),() 9 9 0 0 0 0 1
cell transplantation, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,()-.- 6 9 0 0 0 0 1
patients (25%) patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ()().,() 8 9 0 0 0 0 1
after a after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -.- 3 9 0 0 0 0 1
bilirubin levels, bilirubin b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,-.- 4 10 0 0 0 0 1
able analysis, able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,-,- 4 9 0 0 0 0 1
overall mortality. overall o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .,- 3 9 0 0 0 0 1
significant early significant s si sig sign BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .. 2 6 0 0 0 0 1
Correspondence: E. correspondence: C Co Cor Corr BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 :. 2 10 1 1 0 0 1
elena.sieni@meyer.it elena.sieni@meyer.it elena.sieni@meyer.it e el ele elen BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 9 .@. 3 10 1 1 0 0 1
Received: Received: received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 5 1 1 0 0 1
July 19, july J Ju Jul July BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 9 ,. 2 7 1 1 0 0 1
Accepted: Accepted: accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 5 1 1 0 0 1
February 12, february F Fe Feb Febr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 9 ,. 2 10 1 1 0 0 1
Early view: early E Ea Ear Earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 9 : 1 6 1 1 0 0 1
February 22, february F Fe Feb Febr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 9 ,. 2 10 1 1 0 0 1
https://doi.org/10.3324/haematol.2023.283893 https://doi.org/10.3324/haematol.2023.283893 https://doi.org/10.3324/haematol.2023.283893 h ht htt http BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 10 ://././.. 9 10 1 0 0 0 1
©2024 Ferrata ©2024 © ©2 ©20 ©202 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 10 no 0 10 1 0 0 0 1
Published under published P Pu Pub Publ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 - 1 10 1 0 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 1 0 0 1
Primary hemophagocytic primary P Pr Pri Prim BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 () 2 9 0 1 0 0 1
rare and rare r ra rar rare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 . 1 10 0 1 0 0 1
It encompasses it I It It It BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 9 0 1 0 0 1
most cases most m mo mos most BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 - 1 9 0 1 0 0 1
cytotoxic pathway cytotoxic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 (), 3 9 0 1 0 0 1
which were which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 '.-, 4 10 0 1 0 0 1
the diagnosis the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 9 0 1 0 0 1
laboratory criteria, laboratory l la lab labo BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ,- 2 9 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 0 0 1 0 0
2516 2516 2516 2 25 251 2516 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 0 no 0 10 0 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 10 0 1 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 .. 2 4 0 1 0 0 0
function, and function, f fu fun func BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ."", 4 9 0 1 0 0 1
as follows, as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,:- 3 8 0 1 0 0 1
mophagocytic lymphohistiocytosis mophagocytic m mo mop moph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 9 0 1 0 0 1
mutations of mutations m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (),(),(), 9 8 0 1 0 0 1
or STXBP2 or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (); 3 8 0 1 0 0 1
HLH, defined hlh, H HL HLH HLH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,( 2 8 0 1 0 0 1
type 2, type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,),(-,), 8 8 0 1 0 0 1
AP3B1 (Hermansky-Pudlak ap3b1 A AP AP3 AP3B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-,);- 6 8 0 1 0 0 1
lymphoproliferative disease lymphoproliferative l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 8 0 1 0 0 1
of SH2D1A of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()().- 6 8 0 1 0 0 1
syndromes include syndromes s sy syn synd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --, 3 8 0 1 0 0 1
CDC42 heterozygous cdc42 C CD CDC CDC4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ,-() 4 8 0 1 0 0 1
susceptibility diseases susceptibility s su sus susc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 1 0 0 1
deficiencies, and deficiencies, d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,., 3 7 0 1 0 0 1
The clinical the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 1 0 0 1
that of that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,,, 3 9 0 1 0 0 1
hepatosplenomegaly in hepatosplenomegaly h he hep hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .- 2 8 0 1 0 0 1
tral nervous tral t tr tra tral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()( 3 9 0 1 0 0 1
affecting the affecting a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ). 2 8 0 1 0 0 1
abnormalities include abnormalities a ab abn abno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 8 0 1 0 0 1
and abnormal and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 1 0 0 1
tor (sIL2R). tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ().,, 5 9 0 1 0 0 1
pHLH in phlh p pH pHL pHLH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 1 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
cytometry of cytometry c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
surface CD107a surface s su sur surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 7 0 1 0 0 1
Hematopoietic stem hematopoietic H He Hem Hema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ()- 3 8 0 1 0 0 1
ly curative ly l ly ly ly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 0 . 1 8 0 1 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
the Histiocyte the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 0 1 0 0 1
considered the considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .- 2 8 0 1 0 0 1
tive therapeutic tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
approach based approach a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()- 3 8 0 1 0 0 1
ylprednisolone 12 ylprednisolone y yl ylp ylpr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,, 2 9 0 1 0 0 1
alemtuzumab, 13 alemtuzumab, a al ale alem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,., 4 10 0 1 0 0 1
pHLH remains phlh p pH pHL pHLH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -- 2 8 0 1 0 0 1
mortality and mortality m mo mor mort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -. 2 5 0 1 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 , 1 8 0 1 0 0 1
diagnostic strategies, diagnostic d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 1 0 0 1
in patients in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 ., 2 8 0 1 0 0 1
the syndrome, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 1 0 0 1
the genetic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,., 3 8 0 1 0 0 1
analyzed a analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 , 1 9 0 1 0 0 1
to analyze to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 8 0 1 0 0 1
come. In come. c co com come BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 1 0 0 1
response and response r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 6 0 1 0 0 1
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 10 0 0 0 0 1
Study population study S St Stu Stud BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 3 0 0 0 0 1
Clinical data clinical C Cl Cli Clin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 10 0 0 0 0 1
ceived a ceived c ce cei ceiv BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 0 1 0 0 1
registry held registry r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ', 2 9 0 1 0 0 1
Italy. For italy. I It Ita Ital BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 ., 2 10 0 1 0 0 1
registry data registry r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 0 1 0 0 1
of pHLH of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 9 0 1 0 0 1
reported in reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 0 1 0 0 1
diagnosed after diagnosed d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 0 1 0 0 1
they had they t th the they BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 0 1 0 0 1
tation, and tation, t ta tat tati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ,,- 3 8 0 1 0 0 1
of 12 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 0 1 0 0 1
other countries other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 8 0 1 0 0 1
excluded. Although excluded. e ex exc excl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 9 0 1 0 0 1
were infants were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 9 0 1 0 0 1
study inclusion study s st stu stud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 0 1 0 0 1
Data collection data D Da Dat Data BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 2 0 0 0 0 1
Baseline data baseline B Ba Bas Base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 ,, 2 9 0 0 0 0 1
clinical features clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 9 0 0 0 0 1
laboratory assessment, laboratory l la lab labo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,- 2 7 0 0 0 0 1
2004 diagnostic 2004 2 20 200 2004 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 7 (,, 3 9 0 0 0 0 1
triglycerides, fibrinogen, triglycerides, t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 ,,,). 5 10 0 0 0 0 1
Follow-up data follow-up F Fo Fol Foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 - 1 9 0 0 0 0 1
(including HSCT), (including ( (i (in (inc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (),,- 5 9 0 0 0 0 1
vation, sequelae, vation, v va vat vati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 ,,-. 4 9 0 0 0 0 1
these data these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 -, 2 9 0 0 0 0 1
forms, and forms, f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,,- 3 8 0 0 0 0 1
database. Response database. d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 .-- 3 8 0 0 0 0 1
rized as rized r ri riz rize BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (),(), 6 9 0 0 0 0 1
and non-response and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 -(). 4 9 0 0 0 0 1
provided in provided p pr pro prov BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 7 0 0 0 0 1
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
Continuous variables continuous C Co Con Cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 7 0 0 0 0 1
interquartile range interquartile i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 () 2 9 0 0 0 0 1
absolute number absolute a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 .- 2 8 0 0 0 0 1
ables, multiple-group ables, a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ,- 2 8 0 0 0 0 1
Kruskal-Wallis test, kruskal-wallis K Kr Kru Krus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 -,- 3 9 0 0 0 0 1
Mann-Whitney U mann-whitney M Ma Man Mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 -.- 3 8 0 0 0 0 1
quency, statistical quency, q qu que quen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ,, 2 10 0 0 0 0 1
applicable, or applicable, a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,' 2 9 0 0 0 0 1
ratio (OR). ratio r ra rat rati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ().,( 5 8 0 0 0 0 1
CI) was ci) C CI CI) CI) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ).,' 4 9 0 0 0 0 1
test with test t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 - 1 8 0 0 0 0 1
tion were tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 .-- 3 9 0 0 0 0 1
(survival analysis) (survival ( (s (su (sur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ()- 3 9 0 0 0 0 1
the log-rank the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 -., 3 9 0 0 0 0 1
regression model regression r re reg regr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 9 0 0 0 0 1
multivariate analyses, multivariate m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 , 1 9 0 0 0 0 1
models (binomial models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 (). 3 8 0 0 0 0 1
variables were variables v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 8 0 0 0 0 1
the maximum the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 9 0 0 0 0 1
an optimal an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 9 no 0 8 0 0 0 0 1
relevant clinical relevant r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 .-. 3 9 0 0 0 0 1
significant. Statistical significant. s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 8 0 0 0 0 1
software version software s so sof soft BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ... 3 3 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 0 1 0 0
2517 2517 2517 2 25 251 2517 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 0 no 0 10 0 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 10 0 0 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 .. 2 4 0 0 0 0 0
Ethics statement ethics E Et Eth Ethi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 2 0 1 0 0 1
The study the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 1 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 0 1 0 0 1
consent was consent c co con cons BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 1 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
Three hundred three T Th Thr Thre BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
included in included i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
excluded because excluded e ex exc excl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
because they because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
because of because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -, 2 9 0 0 0 0 1
had received had h ha had had BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 10 0 0 0 0 1
were included were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 6 0 0 0 0 1
Patients' characteristics patients' P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 ' 1 6 0 0 0 0 1
The baseline the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
are detailed are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
12 months 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 1 ([],-). 7 9 0 0 0 0 1
patients were patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 9 0 0 0 0 1
patients (10%) patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 () 2 9 0 0 0 0 1
(8%) were (8%) ( (8 (8% (8%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 (). 3 9 0 0 0 0 1
(N=88, 62%). (n=88, ( (N (N= (N=8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 (,). 4 9 0 0 0 0 1
(N=113, 79%), (n=113, ( (N (N= (N=1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 (,), 4 9 0 0 0 0 1
North Africa north N No Nor Nort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 1 (,),(,), 8 9 0 0 0 0 1
Latin America, latin L La Lat Lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 1 ,-(, 4 9 0 0 0 0 1
2%, for 2%, 2 2% 2%, 2%, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 ,).() 5 9 0 0 0 0 1
parents, and parents, p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,(). 4 7 0 0 0 0 1
Ninety-two patients ninety-two N Ni Nin Nine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 -()- 4 9 0 0 0 0 1
diagnosis. 16 diagnosis. d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .-() 4 9 0 0 0 0 1
fever, 120 fever, f fe fev feve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,(),(). 7 9 0 0 0 0 1
CNS involvement cns C CN CNS CNS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 (/ 2 9 0 0 0 0 1
or abnormalities or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 - 1 8 0 0 0 0 1
brospinal fluid brospinal b br bro bros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 )(). 4 9 0 0 0 0 1
At least at A At At At BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 (): 3 9 0 0 0 0 1
the median the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 /(,.-), 7 9 0 0 0 0 1
median neutrophil median m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ./(,.-.), 9 10 0 0 0 0 1
median platelet median m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 /(,-).- 7 9 0 0 0 0 1
patients (50%) patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (): 3 9 0 0 0 0 1
aspartate and aspartate a as asp aspa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
and 132 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 /(,--,), 8 9 0 0 0 0 1
the median the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ./(,.-.). 9 10 0 0 0 0 1
The median the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 ,, 2 9 0 0 0 0 1
were 2,538 were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,/(,,-,),/(,- 13 9 0 0 0 0 1
428), and 428), 4 42 428 428) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 ),/(,-),. 9 9 0 0 0 0 1
triggers were triggers t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 () 2 8 0 0 0 0 1
consisted of consisted c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (,)(, 5 8 0 0 0 0 1
10%). Four 10%). 1 10 10% 10%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 ). 2 9 0 0 0 0 1
based on based b ba bas base BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 4 0 0 0 0 1
Genetic diagnosis genetic G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 3 0 1 0 0 1
The genetic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 .-(),() 7 9 0 1 0 0 1
FHL3, two fhl3, F FH FHL FHL3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ,(),(),(), 10 10 0 1 0 0 1
(6%) XLP2, (6%) ( (6 (6% (6%) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 (),(),(). 9 10 0 1 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 .. 2 10 0 1 0 0 1
Charactersitics Charactersitics charactersitics C Ch Cha Char BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 8 0 1 0 0 1
Included patients included I In Inc Incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 1 0 0 1
N=143 N=143 n=143 N N= N=1 N=14 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 3 0 1 0 0 1
Age in age A Ag Age Age BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,() 3 10 0 1 0 0 1
12 (2-81) 12 1 12 12 12 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 7 (-) 3 3 0 1 0 0 1
Female sex, female F Fe Fem Fema BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,() 3 10 0 1 0 0 1
55 (38) 55 5 55 55 55 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 7 () 2 4 0 1 0 0 1
Ethnic origin, ethnic E Et Eth Ethn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,() 3 10 0 0 0 0 1
Caucasian Caucasian caucasian C Ca Cau Cauc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 4 0 0 0 0 1
Sub-Saharan African sub-saharan S Su Sub Sub- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 - 1 9 0 0 0 0 1
North African north N No Nor Nort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 7 no 0 6 0 0 0 0 1
Middle East, middle M Mi Mid Midd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 , 1 9 0 0 0 0 1
Indian subcontinent indian I In Ind Indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 9 0 0 0 0 1
Latin American latin L La Lat Lati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 7 no 0 7 0 0 0 0 1
113 (79) 113 1 11 113 113 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 7 () 2 10 0 0 0 0 1
3 (2) 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 () 2 6 0 0 0 0 1
12 (8) 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 7 () 2 7 0 0 0 0 1
3 (2) 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 () 2 6 0 0 0 0 1
9 (6) 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 () 2 6 0 0 0 0 1
3 (2) 3 3 3 3 3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 () 2 6 0 0 0 0 1
Familial disease, familial F Fa Fam Fami BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,() 3 10 0 0 0 0 1
38 (27) 38 3 38 38 38 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 7 () 2 3 0 0 0 0 1
Parental consanguinity, parental P Pa Par Pare BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,() 3 10 0 0 0 0 1
30 (21) 30 3 30 30 30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 2 0 0 0 0 1
Complete HLH-2004 complete C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 -,() 4 10 0 0 0 0 1
92 (64) 92 9 92 92 92 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 2 0 0 0 0 1
Fever , fever F Fe Fev Feve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,() 3 10 0 0 0 0 1
128 (90) 128 1 12 128 128 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 6 0 0 0 0 1
Splenomegaly, N splenomegaly, S Sp Spl Sple BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,() 3 10 0 0 0 0 1
120 (84) 120 1 12 120 120 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 4 0 0 0 0 1
Hepatomegaly, N hepatomegaly, H He Hep Hepa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,() 3 10 0 0 0 0 1
84 (59) 84 8 84 84 84 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 4 0 0 0 0 1
CNS involvement*, cns C CN CNS CNS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 *,() 4 10 0 0 0 0 1
49 (34) 49 4 49 49 49 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 3 0 0 0 0 1
Cytopenia (at cytopenia C Cy Cyt Cyto BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 (),() 5 10 0 0 0 0 1
97 (68) 97 9 97 97 97 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 () 2 2 0 0 0 0 1
Hemoglobin g/dL, hemoglobin H He Hem Hemo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 /,() 4 10 0 0 0 0 1
8 (7.7-10) 8 8 8 8 8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 8 (.-) 4 3 0 0 0 0 1
ANC x10 anc A AN ANC ANC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
0.76 (0.33-1.73) 0.76 0 0. 0.7 0.76 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .(.-.) 6 6 0 0 0 0 1
PLT x10 plt P PL PLT PLT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
48 (24-100) 48 4 48 48 48 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 (-) 3 4 0 0 0 0 1
Fibrinogen mg/dL, fibrinogen F Fi Fib Fibr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
121 (80-228) 121 1 12 121 121 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 (-) 3 4 0 0 0 0 1
Triglycerides mg/dL, triglycerides T Tr Tri Trig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
278 (185-428) 278 2 27 278 278 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 (-) 3 4 0 0 0 0 1
Ferritin ng/mL, ferritin F Fe Fer Ferr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
2,538 (1,061-11,550) 2,538 2 2, 2,5 2,53 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 9 ,(,-,) 6 7 0 0 0 0 1
ALT UI/L, alt A AL ALT ALT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /,() 4 10 0 0 0 0 1
132 (56-279) 132 1 13 132 132 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 (-) 3 5 0 0 0 0 1
AST UI/L, ast A AS AST AST BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 /,() 4 10 0 0 0 0 1
164 (66-386) 164 1 16 164 164 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 (-) 3 5 0 0 0 0 1
Bilirubin mg/dL, bilirubin B Bi Bil Bili BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 /,() 4 10 0 0 0 0 1
1.1 (0.5-2.9) 1.1 1 1. 1.1 1.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 .(.-.) 6 4 0 0 0 0 1
Infectious trigger, infectious I In Inf Infe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 ,() 3 10 0 1 0 0 1
EBV EBV ebv E EB EBV EBV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
CMV CMV cmv C CM CMV CMV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
HHV6-7 HHV6-7 hhv6-7 H HH HHV HHV6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 - 1 2 0 1 0 0 1
Parvovirus Parvovirus parvovirus P Pa Par Parv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 4 0 1 0 0 1
Others # others O Ot Oth Othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 # 1 3 0 1 0 0 1
NA NA na N NA NA NA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
42 (29) 42 4 42 42 42 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 () 2 10 0 1 0 0 1
21 (50) 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 () 2 10 0 1 0 0 1
4 (10) 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 () 2 8 0 1 0 0 1
2 (5) 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 () 2 7 0 1 0 0 1
3 (7) 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 () 2 7 0 1 0 0 1
3 (7) 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 () 2 7 0 1 0 0 1
9 (21) 9 9 9 9 9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 () 2 8 0 1 0 0 1
*Central nervous *central * *C *Ce *Cen BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 *()- 4 9 0 1 0 0 1
ence of ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 :);) 4 10 0 1 0 0 1
magnetic resonance magnetic m ma mag magn BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ;); 3 9 0 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 # 1 10 0 1 0 0 1
others include others o ot oth othe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 .,.,,,.- 8 9 0 1 0 0 1
monia, SARS-CoV-2, monia, m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ,--,.:;: 8 9 0 1 0 0 1
absolute neutrophil absolute a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 ;:;:- 5 9 0 1 0 0 1
nases; AST: nases; n na nas nase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ;:;:-;: 7 10 0 1 0 0 1
cytomegalovirus; HHV6: cytomegalovirus; c cy cyt cyto BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ;:-;:. 6 9 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 1 0 1 0 0
2518 2518 2518 2 25 251 2518 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 0 no 0 10 1 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 10 1 1 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 .. 2 4 1 1 0 0 0
differences in differences d di dif diff BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
genetic diagnosis genetic g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (; 2 9 0 0 0 0 1
Supplementary Figure supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ),, 3 9 0 0 0 0 1
consanguinity, and consanguinity, c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,(- 3 10 0 0 0 0 1
ing the ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
abnormalities, ferritin abnormalities, a ab abn abno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,- 3 9 0 0 0 0 1
gers). In gers). g ge ger gers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 )., 3 9 0 0 0 0 1
lower rates lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ( 1 9 0 0 0 0 1
platelet and platelet p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,). 3 9 0 0 0 0 1
When we when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
in three in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 (-,-, 5 8 0 0 0 0 1
months; Online months; m mo mon mont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ;), 3 9 0 0 0 0 1
of patients of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
three age three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
than 2 than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,, 3 9 0 0 0 0 1
typically younger. typically t ty typ typi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 3 0 0 0 0 1
Response to response R Re Res Resp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 3 1 1 0 0 1
Thirteen patients thirteen T Th Thi Thir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 (),- 4 9 1 1 0 0 1
ther for ther t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (), 3 9 1 1 0 0 1
presentation (N=3), presentation p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (),(). 6 8 1 1 0 0 1
First-line therapies first-line F Fi Fir Firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 9 1 1 0 0 1
chemotherapy according chemotherapy c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 -- 2 9 1 1 0 0 1
trials in trials t tr tri tria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ()(),, 6 10 1 1 0 0 1
seven patients seven s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ()- 3 9 1 1 0 0 1
(EUDRACT2011-002052-14). The (eudract2011-002052-14). ( (E (EU (EUD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 5 (--).() 7 9 1 1 0 0 1
received steroid-based received r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -(;- 4 9 1 1 0 0 1
mentary Table mentary m me men ment BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ). 2 3 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 .- 2 9 1 1 0 0 1
tients. FHL2: tients. t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 9 .: 2 9 1 1 0 0 1
2; FHL3: 2; 2 2; 2; 2; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 ;:; 3 9 1 1 0 0 1
FHL4: familial fhl4: F FH FHL FHL4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 :; 2 8 1 1 0 0 1
FHL5: familial fhl5: F FH FHL FHL5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 :;: 3 9 1 1 0 0 1
Griscelli syndrome griscelli G Gr Gri Gris BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 9 ;:-; 4 8 1 1 0 0 1
XLP1: X-linked xlp1: X XL XLP XLP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 :-;:- 5 10 1 1 0 0 1
lymphoproliferative disease lymphoproliferative l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 9 ;: 2 9 1 1 0 0 1
type 2. type t ty typ type BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 . 1 1 1 1 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 .-.:. 5 10 1 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 0 1 0 0
2519 2519 2519 2 25 251 2519 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 0 no 0 10 1 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 10 0 1 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .. 2 4 0 1 0 0 0
The overall the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 (/; 3 9 1 1 0 0 1
Figure 2). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ). 2 9 1 1 0 0 1
in 21 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 (). 3 9 1 1 0 0 1
In 11 in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 0 ,: 2 9 1 1 0 0 1
rituximab in rituximab r ri rit ritu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,- 3 9 1 1 0 0 1
tinib, and tinib, t ti tin tini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,, 2 9 1 1 0 0 1
tacrolimus in tacrolimus t ta tac tacr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 .-() 4 9 1 1 0 0 1
not respond not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 : 1 8 1 1 0 0 1
as salvage as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 1 1 0 0 1
remaining 24 remaining r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (- 2 9 1 1 0 0 1
ed to ed e ed ed ed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 0 -), 3 10 1 1 0 0 1
median follow-up median m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(,-)(). 8 9 1 1 0 0 1
patients who patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -, 2 9 1 1 0 0 1
19 (84%) 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 ()(,),., 8 9 1 1 0 0 1
all these all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 1 0 0 1
(CNS) involvement (cns) ( (C (CN (CNS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (). 3 5 1 1 0 0 1
Eight patients eight E Ei Eig Eigh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 1 0 0 1
treatment (N=1), treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (),(- 5 9 1 1 0 0 1
nosed due nosed n no nos nose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ),(); 5 10 1 1 0 0 1
these latter these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 1 0 0 1
a median a a a a a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 0 -(,-)(). 8 9 1 1 0 0 1
No significant no N No No No BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 - 1 9 0 1 0 0 1
ment or ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 9 0 1 0 0 1
therapeutic protocol therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 (), 3 9 0 1 0 0 1
patients who patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 - 1 9 0 1 0 0 1
age, higher age, a ag age age, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ,, 2 10 0 1 0 0 1
(Figure 3). (figure ( (F (Fi (Fig BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (). 3 1 0 1 0 0 1
Reactivation Reactivation reactivation R Re Rea Reac BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 2 1 0 0 0 1
Thirty-three of thirty-three T Th Thi Thir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 -()- 4 9 1 0 0 0 1
ment reactivated, ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 , 1 9 1 0 0 0 1
months (IQR, months m mo mon mont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (,-)., 6 8 1 0 0 0 1
first-line chemotherapy first-line f fi fir firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 -- 2 8 1 0 0 0 1
dian time dian d di dia dian BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 7 .(,.-): 7 9 1 0 0 0 1
child died child c ch chi chil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 7 no 0 9 1 0 0 0 1
treatment, while treatment, t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 9 1 0 0 0 1
alive at alive a al ali aliv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 - 1 10 1 0 0 0 1
disease progression disease d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (). 3 9 1 0 0 0 1
16 patients 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 7 ,- 2 9 1 0 0 0 1
motherapy according motherapy m mo mot moth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 -(, 3 9 1 0 0 0 1
with alemtuzumab, with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,,) 3 8 1 0 0 0 1
emapalumab (5 emapalumab e em ema emap BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 (;). 4 9 1 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEEND SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 ..:. 4 10 1 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 1 1 1 0 0
2520 2520 2520 2 25 252 2520 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 0 no 0 10 1 1 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 10 0 0 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 .. 2 4 0 0 0 0 0
Nine of nine N Ni Nin Nine BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
six of six s si six six BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
(Figure 2). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ().,- 5 9 0 0 0 0 1
chemotherapy, partial chemotherapy, c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
re-intensification treatment, re-intensification r re re- re-i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -,: 3 9 0 0 0 0 1
two received two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
time from time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(,-;- 6 9 0 0 0 0 1
mentary Table mentary m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ;). 3 9 0 0 0 0 1
steroid treatment steroid s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -, 2 9 0 0 0 0 1
four of four f fo fou four BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ; 1 9 0 0 0 0 1
median follow-up median m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -(,-). 6 9 0 0 0 0 1
reactivation-free survival reactivation-free r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 - 1 10 0 0 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 .- 2 9 0 0 0 0 1
found according found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
period (Online period p pe per peri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (-). 4 7 0 0 0 0 1
Transplantation Transplantation transplantation T Tr Tra Tran BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 2 no 0 2 1 1 0 0 1
Ninety-two of ninety-two N Ni Nin Nine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 -(),- 5 9 1 1 0 0 1
dian time dian d di dia dian BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 2 (,-.). 6 9 1 1 0 0 1
of them of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 9 1 1 0 0 1
an additional an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 . 1 9 1 1 0 0 1
patients, 78 patients, p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,() 3 9 1 1 0 0 1
median time median m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 (,-) 4 9 1 1 0 0 1
and 56 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 (,-)(). 7 9 1 1 0 0 1
14 patients 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 2 , 1 9 1 1 0 0 1
due to due d du due due BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 10 1 1 0 0 1
and 11 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 -. 2 9 1 1 0 0 1
able to able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 1 1 0 0 1
counts and counts c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 (). 3 9 1 1 0 0 1
Interestingly, 15 interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 ,() 3 9 1 1 0 0 1
were alive were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 9 1 1 0 0 1
(IQR, 13-55; (iqr, ( (I (IQ (IQR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 2 (,-;). 6 9 1 1 0 0 1
responded to responded r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 -, 2 9 1 1 0 0 1
who reactivated who w wh who who BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -- 2 9 0 0 0 0 1
ment. Five ment. m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 .: 2 9 0 0 0 0 1
were diagnosed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
disease-free through disease-free d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 --, 3 9 0 0 0 0 1
isolated CNS isolated i is iso isol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 10 0 0 0 0 1
follow-up at follow-up f fo fol foll BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -. 2 4 0 0 0 0 1
Survival Survival survival S Su Sur Surv BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 1 1 1 0 0 1
Ninety-three patients ninety-three N Ni Nin Nine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 -()- 4 10 1 1 0 0 1
(Figure 4). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ().- 4 9 1 1 0 0 1
(IQR, 6-74) (iqr, ( (I (IQ (IQR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (,-)(,- 7 9 1 1 0 0 1
97) for 97) 9 97 97) 97) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 )-. 3 9 1 1 0 0 1
patients who patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ,() 3 9 1 1 0 0 1
because they because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 9 1 1 0 0 1
(10%) received (10%) ( (1 (10 (10% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ()(; 4 9 1 1 0 0 1
IQR, 1-6). iqr, I IQ IQR IQR, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,-). 4 9 1 1 0 0 1
(9 HLH-94, (9 ( (9 (9 (9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 (-,-,-). 8 9 1 1 0 0 1
patients, 16 patients, p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ,-- 3 10 1 1 0 0 1
ment (9 ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 (-, 3 9 1 1 0 0 1
reactivation, and reactivation, r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ,), 3 9 1 1 0 0 1
not respond not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 1 1 0 0 1
of 1 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,-)(). 7 9 1 1 0 0 1
Thirty-six patients thirty-six T Th Thi Thir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 -() 3 9 1 1 0 0 1
(Figure 4). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 (). 3 9 1 1 0 0 1
leading to leading l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -(, 3 9 1 1 0 0 1
following HSCT following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ),- 3 9 1 1 0 0 1
11 (22%), 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 6 (),() 5 9 1 1 0 0 1
in two in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 6 ()()., 6 9 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ( 1 9 1 1 0 0 1
exist conflicting exist e ex exi exis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ), 2 9 1 1 0 0 1
HSCT and hsct H HS HSC HSCT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 . 1 7 1 1 0 0 1
When evaluating when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 ,- 2 9 1 1 0 0 1
low-up, according low-up, l lo low low- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -,, 3 9 1 1 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEEND SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 ..:. 4 10 1 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 1 1 0 0
2521 2521 2521 2 25 252 2521 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 0 no 0 10 0 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 10 0 0 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .. 2 4 0 0 0 0 0
significant difference significant s si sig sign BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 0 0 0 0 1
Similarly, no similarly, S Si Sim Simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 9 0 0 0 0 1
lyzing patients lyzing l ly lyz lyzi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
and pigmentary and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ( 1 9 0 0 0 0 1
S4), nor s4), S S4 S4) S4), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ), 2 9 0 0 0 0 1
(2007-2014 vs. (2007-2014 ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 (-.-);, 7 9 0 0 0 0 1
post-transplant survival post-transplant p po pos post BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
(Online Supplementary (online ( (O (On (Onl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (). 3 5 0 0 0 0 1
No significant no N No No No BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
teristics of teristics t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -, 2 10 0 0 0 0 1
while patients while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
counts and counts c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
to those to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 6 0 0 0 0 1
Predictors of predictors P Pr Pre Pred BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 - 1 7 0 1 0 0 1
At unadjusted at A At At At BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 ,- 2 10 0 1 0 0 1
age <6 age a ag age age BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ,(,/), 6 10 0 1 0 0 1
high bilirubin high h hi hig high BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 1 (/). 4 9 0 0 0 0 1
pre-transplant and pre-transplant p pr pre pre- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 - 1 9 0 0 0 0 1
bilirubin levels bilirubin b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 ().- 4 10 0 0 0 0 1
ysis, high ysis, y ys ysi ysis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 , 1 9 0 0 0 0 1
non-response (overall non-response n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 -([].,:.-.; 11 9 0 0 0 0 1
P=0.049), while p=0.049), P P= P=0 P=0. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .),/ 4 9 0 0 0 0 1
as predictors as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 -(.,:.-.; 9 9 0 0 0 0 1
P=0.014) and p=0.014) P P= P=0 P=0. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .)(.,:.-.; 10 9 0 0 0 0 1
P=0.045; Table p=0.045; P P= P=0 P=0. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .;). 4 3 0 0 0 0 1
Sequelae Sequelae sequelae S Se Seq Sequ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 no 0 1 0 1 0 0 1
Sequelae were sequelae S Se Seq Sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 (). 3 10 0 1 0 0 1
92 transplanted 92 9 92 92 92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 2 ()-- 4 9 0 1 0 0 1
lated (chronic lated l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 (--;, 5 9 0 1 0 0 1
vascular, and vascular, v va vas vasc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 ,);- 4 9 0 1 0 0 1
cies (lymphoma, cies c ci cie cies BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 (,, 3 9 0 1 0 0 1
cancer); two cancer); c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 );,- 4 9 0 1 0 0 1
Table 2. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 .-,-,. 6 10 0 1 0 0 1
Non-response Non-response non-response N No Non Non- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 - 1 5 0 1 0 0 1
Death pre-HSCT death D De Dea Deat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 6 0 1 0 0 1
Death at death D De Dea Deat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 10 0 1 0 0 1
Crude OR crude C Cr Cru Crud BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 1 0 0 1
(95% CI) (95% ( (9 (95 (95% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 () 2 10 0 1 0 0 1
P P p P P P P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 no 0 2 0 1 0 0 1
Crude OR crude C Cr Cru Crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 1 0 0 1
(95% CI) (95% ( (9 (95 (95% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 () 2 10 0 1 0 0 1
P P p P P P P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 no 0 2 0 1 0 0 1
Crude OR crude C Cr Cru Crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 1 0 0 1
(95% CI) (95% ( (9 (95 (95% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 () 2 10 0 1 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 no 0 2 0 1 0 0 1
Female sex female F Fe Fem Fema BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 6 0 1 0 0 1
0.93 (0.37-2.32) 0.93 0 0. 0.9 0.93 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 10 0 1 0 0 1
0.881 0.881 0.881 0 0. 0.8 0.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 3 0 1 0 0 1
0.83 (0.37-1.84) 0.83 0 0. 0.8 0.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 10 0 1 0 0 1
0.642 0.642 0.642 0 0. 0.6 0.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 3 0 1 0 0 1
0.68 (0.33-1.41) 0.68 0 0. 0.6 0.68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 10 0 1 0 0 1
0.303 0.303 0.303 0 0. 0.3 0.30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 3 0 1 0 0 1
Age at age A Ag Age Age BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 0 0 0 1
2.95 (1.19-7.33) 2.95 2 2. 2.9 2.95 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 7 0 0 0 0 1
0.017 0.017 0.017 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 2 0 0 0 0 1
1.75 (0.81-3.78) 1.75 1 1. 1.7 1.75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 7 0 0 0 0 1
0.153 0.153 0.153 0 0. 0.1 0.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 2 0 0 0 0 1
1.99 (0.99-4.02) 1.99 1 1. 1.9 1.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .(.-.) 6 7 0 0 0 0 1
0.052 0.052 0.052 0 0. 0.0 0.05 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 . 1 2 0 0 0 0 1
Diagnosis Diagnosis diagnosis D Di Dia Diag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 5 0 0 0 0 1
FHL2 (vs. fhl2 F FH FHL FHL2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 (.) 3 10 0 0 0 0 1
FHL3 FHL3 fhl3 F FH FHL FHL3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
FHL4 FHL4 fhl4 F FH FHL FHL4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
FHL5 FHL5 fhl5 F FH FHL FHL5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
XLP1 XLP1 xlp1 X XL XLP XLP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
XLP2 XLP2 xlp2 X XL XLP XLP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
GS2 GS2 gs2 G GS GS2 GS2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
CHS CHS chs C CH CHS CHS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 no 0 2 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 - 1 0 0 0 0 0 1
2.17 (0.75-6.89) 2.17 2 2. 2.1 2.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(.-.) 6 9 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (-) 3 6 0 0 0 0 1
2.47 (0.56-17.42) 2.47 2 2. 2.4 2.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(.-.) 6 10 0 0 0 0 1
1.20 (0.29-6.12) 1.20 1 1. 1.2 1.20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(.-.) 6 9 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (-) 3 6 0 0 0 0 1
3.14 (0.49-61.80) 3.14 3 3. 3.1 3.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(.-.) 6 10 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (-) 3 6 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 - 1 1 0 0 0 0 1
0.167 0.167 0.167 0 0. 0.1 0.16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.997 0.997 0.997 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.282 0.282 0.282 0 0. 0.2 0.28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.813 0.813 0.813 0 0. 0.8 0.81 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.994 0.994 0.994 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.307 0.307 0.307 0 0. 0.3 0.30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
0.995 0.995 0.995 0 0. 0.9 0.99 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 - 1 0 0 0 0 0 1
1.82 (0.69-5.08) 1.82 1 1. 1.8 1.82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(.-.) 6 10 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (-) 3 6 0 0 0 0 1
1.88 (0.50-9.12) 1.88 1 1. 1.8 1.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(.-.) 6 10 0 0 0 0 1
0.94 (0.25-3.96) 0.94 0 0. 0.9 0.94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(.-.) 6 10 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (-) 3 6 0 0 0 0 1
0.59 (0.14-2.66) 0.59 0 0. 0.5 0.59 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(.-.) 6 10 0 0 0 0 1
3.28 (0.52-64.2) 3.28 3 3. 3.2 3.28 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(.-.) 6 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 - 1 1 0 0 0 0 1
0.237 0.237 0.237 0 0. 0.2 0.23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.995 0.995 0.995 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.381 0.381 0.381 0 0. 0.3 0.38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.925 0.925 0.925 0 0. 0.9 0.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.990 0.990 0.990 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.470 0.470 0.470 0 0. 0.4 0.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.286 0.286 0.286 0 0. 0.2 0.28 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 - 1 0 0 0 0 0 1
1.79 (0.74-4.43) 1.79 1 1. 1.7 1.79 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(.-.) 6 10 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (-) 3 6 0 0 0 0 1
1.11 (0.34-3.79) 1.11 1 1. 1.1 1.11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(.-.) 6 10 0 0 0 0 1
1.04 (0.29-3.95) 1.04 1 1. 1.0 1.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(.-.) 6 10 0 0 0 0 1
inf (0-NA) inf i in inf inf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (-) 3 6 0 0 0 0 1
0.59 (0.13-2.51) 0.59 0 0. 0.5 0.59 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(.-.) 6 10 0 0 0 0 1
5.19 (0.83-101) 5.19 5 5. 5.1 5.19 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(.-) 5 9 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 - 1 1 0 0 0 0 1
0.198 0.198 0.198 0 0. 0.1 0.19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.995 0.995 0.995 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.862 0.862 0.862 0 0. 0.8 0.86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.956 0.956 0.956 0 0. 0.9 0.95 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.990 0.990 0.990 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.475 0.475 0.475 0 0. 0.4 0.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
0.138 0.138 0.138 0 0. 0.1 0.13 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
Clinical presentation clinical C Cl Cli Clin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 7 0 0 0 0 1
Complete HLH complete C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 7 0 0 0 0 1
Fever Fever fever F Fe Fev Feve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 2 0 0 0 0 1
Splenomegaly Splenomegaly splenomegaly S Sp Spl Sple BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 4 0 0 0 0 1
Hepatomegaly Hepatomegaly hepatomegaly H He Hep Hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 4 0 0 0 0 1
CNS involvement cns C CN CNS CNS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 5 0 0 0 0 1
Hemoglobin <8 hemoglobin H He Hem Hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 / 1 6 0 0 0 0 1
ANC <0.5x10 anc A AN ANC ANC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 ./ 2 6 0 0 0 0 1
PLT <20x10 plt P PL PLT PLT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 / 1 5 0 0 0 0 1
Cytopenia at cytopenia C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
Ferritin ≥5,000 ferritin F Fe Fer Ferr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 ,/ 2 7 0 0 0 0 1
Triglycerides ≥265 triglycerides T Tr Tri Trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 / 1 8 0 0 0 0 1
Fibrinogen ≤150 fibrinogen F Fi Fib Fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 / 1 7 0 0 0 0 1
AST >2xULN ast A AS AST AST BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 3 0 0 0 0 1
ALT >2xULN alt A AL ALT ALT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 3 0 0 0 0 1
Bilirubin >2 bilirubin B Bi Bil Bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 / 1 6 0 0 0 0 1
Infectious trigger infectious I In Inf Infe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 6 0 0 0 0 1
0.75 (0.30-1.90) 0.75 0 0. 0.7 0.75 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.72 (0.20-81.3) 1.72 1 1. 1.7 1.72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.04 (0.25-6.23) 1.04 1 1. 1.0 1.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
0.59 (0.23-1.49) 0.59 0 0. 0.5 0.59 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.58 (0.57-4.36) 1.58 1 1. 1.5 1.58 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
0.90 (0.35-2.34) 0.90 0 0. 0.9 0.90 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.07 (0.39-2.91) 1.07 1 1. 1.0 1.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
2.77 (0.87-8.46) 2.77 2 2. 2.7 2.77 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.27 (0.46-3.53) 1.27 1 1. 1.2 1.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
6.73 (2.36-19.20) 6.73 6 6. 6.7 6.73 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 10 0 0 0 0 1
0.99 (0.38-2.55) 0.99 0 0. 0.9 0.99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.22 (0.44-3.34) 1.22 1 1. 1.2 1.22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
0.85 (0.21-4.21) 0.85 0 0. 0.8 0.85 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
1.50 (0.34-9.25) 1.50 1 1. 1.5 1.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
5.53 (1.23-29.29) 5.53 5 5. 5.5 5.53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 10 0 0 0 0 1
0.35 (0.11-1.10) 0.35 0 0. 0.3 0.35 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(.-.) 6 9 0 0 0 0 1
0.541 0.541 0.541 0 0. 0.5 0.54 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
1.000 1.000 1.000 1 1. 1.0 1.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
1.000 1.000 1.000 1 1. 1.0 1.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.259 0.259 0.259 0 0. 0.2 0.25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.372 0.372 0.372 0 0. 0.3 0.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.835 0.835 0.835 0 0. 0.8 0.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.900 0.900 0.900 0 0. 0.9 0.90 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.075 0.075 0.075 0 0. 0.0 0.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.643 0.643 0.643 0 0. 0.6 0.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
<0.001 <0.001 <0.001 < <0 <0. <0.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 10 0 0 0 0 1
0.980 0.980 0.980 0 0. 0.9 0.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.705 0.705 0.705 0 0. 0.7 0.70 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.750 0.750 0.750 0 0. 0.7 0.75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.747 0.747 0.747 0 0. 0.7 0.74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.012 0.012 0.012 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
0.065 0.065 0.065 0 0. 0.0 0.06 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
1.34 (0.57-3.12) 1.34 1 1. 1.3 1.34 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
4.44 (0.62-196.2) 4.44 4 4. 4.4 4.44 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 10 0 0 0 0 1
1.48 (0.46-4.75) 1.48 1 1. 1.4 1.48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.16 (0.51-2.66) 1.16 1 1. 1.1 1.16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.61 (0.67-3.86) 1.61 1 1. 1.6 1.61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.12 (0.49-2.57) 1.12 1 1. 1.1 1.12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.39 (0.58-3.31) 1.39 1 1. 1.3 1.39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
2.14 (0.84-5.51) 2.14 2 2. 2.1 2.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.15 (0.48-2.78) 1.15 1 1. 1.1 1.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
3.47 (1.48-8.13) 3.47 3 3. 3.4 3.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.51 (0.65-3.51) 1.51 1 1. 1.5 1.51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.86 (0.74-4.68) 1.86 1 1. 1.8 1.86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.41 (0.46-4.34) 1.41 1 1. 1.4 1.41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
1.14 (0.39-3.34) 1.14 1 1. 1.1 1.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
5.96 (1.90-18.7) 5.96 5 5. 5.9 5.96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
0.79 (0.33-1.90) 0.79 0 0. 0.7 0.79 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .(.-.) 6 9 0 0 0 0 1
0.497 0.497 0.497 0 0. 0.4 0.49 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.187 0.187 0.187 0 0. 0.1 0.18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.506 0.506 0.506 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.719 0.719 0.719 0 0. 0.7 0.71 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.283 0.283 0.283 0 0. 0.2 0.28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.792 0.792 0.792 0 0. 0.7 0.79 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.455 0.455 0.455 0 0. 0.4 0.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.107 0.107 0.107 0 0. 0.1 0.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.756 0.756 0.756 0 0. 0.7 0.75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.003 0.003 0.003 0 0. 0.0 0.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.336 0.336 0.336 0 0. 0.3 0.33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.182 0.182 0.182 0 0. 0.1 0.18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.550 0.550 0.550 0 0. 0.5 0.55 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.807 0.807 0.807 0 0. 0.8 0.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.001 0.001 0.001 0 0. 0.0 0.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
0.606 0.606 0.606 0 0. 0.6 0.60 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 0 0 0 1
1.43 (0.67-3.05) 1.43 1 1. 1.4 1.43 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.96 (0.48-11.54) 1.96 1 1. 1.9 1.96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 10 0 0 0 0 1
1.42 (0.52-3.92) 1.42 1 1. 1.4 1.42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.08 (0.52-2.25) 1.08 1 1. 1.0 1.08 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.68 (0.78-3.63) 1.68 1 1. 1.6 1.68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.06 (0.50-2.23) 1.06 1 1. 1.0 1.06 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.96 (0.90-4.26) 1.96 1 1. 1.9 1.96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.92 (0.80-4.60) 1.92 1 1. 1.9 1.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
0.98 (0.45-2.13) 0.98 0 0. 0.9 0.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
2.17 (1.01-4.67) 2.17 2 2. 2.1 2.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
0.73 (0.34-1.54) 0.73 0 0. 0.7 0.73 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.01 (0.46-2.22) 1.01 1 1. 1.0 1.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
0.76 (0.30-1.94) 0.76 0 0. 0.7 0.76 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
1.08 (0.42-2.79) 1.08 1 1. 1.0 1.08 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
3.41 (1.41-9.88) 3.41 3 3. 3.4 3.41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
0.70 (0.32-1.53) 0.70 0 0. 0.7 0.70 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(.-.) 6 9 0 0 0 0 1
0.355 0.355 0.355 0 0. 0.3 0.35 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.383 0.383 0.383 0 0. 0.3 0.38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.494 0.494 0.494 0 0. 0.4 0.49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.829 0.829 0.829 0 0. 0.8 0.82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.187 0.187 0.187 0 0. 0.1 0.18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.883 0.883 0.883 0 0. 0.8 0.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.088 0.088 0.088 0 0. 0.0 0.08 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.139 0.139 0.139 0 0. 0.1 0.13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.959 0.959 0.959 0 0. 0.9 0.95 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.044 0.044 0.044 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.409 0.409 0.409 0 0. 0.4 0.40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.976 0.976 0.976 0 0. 0.9 0.97 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.567 0.567 0.567 0 0. 0.5 0.56 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.865 0.865 0.865 0 0. 0.8 0.86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.007 0.007 0.007 0 0. 0.0 0.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
0.368 0.368 0.368 0 0. 0.3 0.36 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
HLH: hemophagocytic hlh: H HL HLH HLH: BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 :;:;:- 6 9 0 1 0 0 1
histiocytosis type histiocytosis h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ;:;:;: 6 9 0 1 0 0 1
X-linked lymphoproliferative x-linked X X- X-l X-li BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 -;:-;:;:-- 10 9 0 1 0 0 1
gashi syndrome; gashi g ga gas gash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ;:;:;:;:;:- 11 9 0 1 0 0 1
aminases; ULN: aminases; a am ami amin BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ;:;:;:;:;:. 11 10 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 1 1 0 0
2522 2522 2522 2 25 252 2522 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 0 no 0 10 0 1 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 10 0 0 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .. 2 4 0 0 0 0 0
ectomy in ectomy e ec ect ecto BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 - 1 9 0 0 0 0 1
in both in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 (,); 4 9 0 0 0 0 1
two had two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,- 2 9 0 0 0 0 1
plant in plant p pl pla plan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,, 2 9 0 0 0 0 1
one pulmonary one o on one one BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ; 1 9 0 0 0 0 1
nervous system nervous n ne ner nerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 8 0 0 0 0 1
complications (paresis complications c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (, 2 9 0 0 0 0 1
epilepsy in epilepsy e ep epi epil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ;- 2 9 0 0 0 0 1
tal spastic tal t ta tal tal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 )., 3 10 0 0 0 0 1
hypogammaglobulinemia and hypogammaglobulinemia h hy hyp hypo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 7 0 0 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 10 0 0 0 0 1
Primary HLH primary P Pr Pri Prim BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 1 0 0 1
of early of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -. 2 9 0 1 0 0 1
course of course c co cou cour BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 1 0 0 1
critical. 8 critical. c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ., 2 9 0 1 0 0 1
investigate the investigate i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -- 2 9 0 1 0 0 1
tients with tients t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 - 1 8 0 1 0 0 1
and mortality. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 2 0 1 0 0 1
In historic in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 1 , 1 8 0 1 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 9 0 1 0 0 1
of diagnosis of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 --- 3 9 0 1 0 0 1
creased. 18,19 creased. c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,,, 4 10 0 1 0 0 1
were younger were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 1 0 0 1
were adolescents were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 8 0 1 0 0 1
the improvement the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 1 0 0 1
increased awareness increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 1 0 0 1
domain. Moreover, domain. d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,, 3 9 0 1 0 0 1
a higher a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 1 , 1 9 0 1 0 0 1
in our in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 . 1 9 0 1 0 0 1
had less had h ha had had BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ., 2 8 0 1 0 0 1
unsurprisingly, the unsurprisingly, u un uns unsu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 , 1 9 0 1 0 0 1
the traditional the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 8 0 1 0 0 1
lower compared lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 1 0 0 1
and from and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ., 2 7 0 1 0 0 1
With regard with W Wi Wit With BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 1 0 0 1
coordinated by coordinated c co coo coor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 9 0 1 0 0 1
standard of standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,, 2 9 0 1 0 0 1
of survival of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,-- 4 9 0 1 0 0 1
vide any vide v vi vid vide BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 -, 2 8 0 1 0 0 1
mortality rate mortality m mo mor mort BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .,- 3 8 0 1 0 0 1
remained the remained r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ., 2 9 0 1 0 0 1
received one received r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 , 1 8 0 1 0 0 1
HLH-94 or hlh-94 H HL HLH HLH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 --., 4 9 0 1 0 0 1
early mortality early e ea ear earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 4 , 1 10 0 1 0 0 1
which those which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 9 0 1 0 0 1
Turkish studies turkish T Tu Tur Turk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 , 1 9 0 1 0 0 1
63% 22 63% 6 63 63% 63% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 .-- 3 8 0 1 0 0 1
studies, we studies, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ,- 2 9 0 1 0 0 1
(15% vs. (15% ( (1 (15 (15% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 (.,),- 6 8 0 1 0 0 1
tially reflects tially t ti tia tial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 no 0 8 0 1 0 0 1
and supportive and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 6 0 1 0 0 1
A minority a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 8 4 (.., 4 8 0 1 0 0 1
emapalumab, ruxolitinib, emapalumab, e em ema emap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ,,)- 4 8 0 1 0 0 1
tion, and tion, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ,. 2 8 0 1 0 0 1
However, we however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 ,- 2 8 0 1 0 0 1
pact due pact p pa pac pact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 8 0 1 0 0 1
contrast, patients contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ,- 2 9 0 1 0 0 1
experienced adverse experienced e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 , 1 8 0 1 0 0 1
those few those t th tho thos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 - 1 8 0 1 0 0 1
treatment (only treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ( 1 8 0 1 0 0 1
emapalumab). This emapalumab). e em ema emap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ). 2 8 0 1 0 0 1
benefit from benefit b be ben bene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 5 0 1 0 0 1
Thus, early thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 , 1 9 0 1 0 0 1
highest risk highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 - 1 8 0 1 0 0 1
tic approaches tic t ti tic tic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .- 2 8 0 1 0 0 1
study indicated study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ,, 2 9 0 1 0 0 1
abnormalities were abnormalities a ab abn abno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .- 2 9 0 1 0 0 1
ditional analysis ditional d di dit diti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 no 0 9 0 1 0 0 1
μmol/L, hyperferritinemia, μmol/l, μ μm μmo μmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 /,, 3 9 0 1 0 0 1
predictors of predictors p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ., 2 9 0 1 0 0 1
Turkish study turkish T Tu Tur Turk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 - 1 8 0 1 0 0 1
ed, at ed, e ed ed, ed, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ,,- 3 9 0 1 0 0 1
patients with patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 9 0 1 0 0 1
study, we study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ,-- 3 9 0 1 0 0 1
treatment, and treatment, t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ,- 2 9 0 1 0 0 1
patients with patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .- 2 8 0 1 0 0 1
cantly associated cantly c ca can cant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 -, 2 9 0 1 0 0 1
values were values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 -,-, 4 9 0 1 0 0 1
and overall and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .,-, 4 9 0 1 0 0 1
ng/mL previously ng/ml n ng ng/ ng/m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 /. 2 9 0 1 0 0 1
statistical significance statistical s st sta stat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 , 1 9 0 1 0 0 1
Table 3. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 .-,-,. 6 10 0 1 0 0 1
Non-response Non-response non-response N No Non Non- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 - 1 5 0 1 0 0 1
Death pre-HSCT death D De Dea Deat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 - 1 6 0 1 0 0 1
Death at death D De Dea Deat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 - 1 10 0 1 0 0 1
OR (95% or O OR OR OR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 () 2 10 0 1 0 0 1
P P p P P P P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 9 no 0 1 0 1 0 0 1
OR (95% or O OR OR OR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 () 2 10 0 1 0 0 1
P P p P P P P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 9 no 0 1 0 1 0 0 1
OR (95% or O OR OR OR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 () 2 10 0 1 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 9 no 0 1 0 1 0 0 1
Age at age A Ag Age Age BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 10 0 1 0 0 1
1.51 (0.29-7.62) 1.51 1 1. 1.5 1.51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.611 0.611 0.611 0 0. 0.6 0.61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
0.60 (0.14-2.14) 0.60 0 0. 0.6 0.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.450 0.450 0.450 0 0. 0.4 0.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
1.16 (0.40-3.25) 1.16 1 1. 1.1 1.16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.773 0.773 0.773 0 0. 0.7 0.77 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
PLT <20x10 plt P PL PLT PLT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 / 1 9 0 1 0 0 1
3.24 (0.57-17.9) 3.24 3 3. 3.2 3.24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 10 0 1 0 0 1
0.173 0.173 0.173 0 0. 0.1 0.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 3 0 1 0 0 1
1.51 (0.33-6.21) 1.51 1 1. 1.5 1.51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 10 0 1 0 0 1
0.579 0.579 0.579 0 0. 0.5 0.57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 3 0 1 0 0 1
1.58 (0.42-5.70) 1.58 1 1. 1.5 1.58 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 10 0 1 0 0 1
0.486 0.486 0.486 0 0. 0.4 0.48 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 3 0 1 0 0 1
Ferritin ≥5,000 ferritin F Fe Fer Ferr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 ,/ 2 10 0 1 0 0 1
5.66 (1.12-42.4) 5.66 5 5. 5.6 5.66 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.049 0.049 0.049 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
2.72 (0.79-9.68) 2.72 2 2. 2.7 2.72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.112 0.112 0.112 0 0. 0.1 0.11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
1.26 (0.43-3.53) 1.26 1 1. 1.2 1.26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(.-.) 6 7 0 1 0 0 1
0.667 0.667 0.667 0 0. 0.6 0.66 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 2 0 1 0 0 1
Bilirubin ≥2 bilirubin B Bi Bil Bili BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 / 1 10 0 1 0 0 1
1.69 (0.29-9.19) 1.69 1 1. 1.6 1.69 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .(.-.) 6 8 0 1 0 0 1
0.538 0.538 0.538 0 0. 0.5 0.53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 . 1 3 0 1 0 0 1
4.89 (1.39-18.6) 4.89 4 4. 4.8 4.89 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .(.-.) 6 8 0 1 0 0 1
0.014 0.014 0.014 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 . 1 3 0 1 0 0 1
2.98 (1.02-8.86) 2.98 2 2. 2.9 2.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .(.-.) 6 8 0 1 0 0 1
0.045 0.045 0.045 0 0. 0.0 0.04 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 . 1 3 0 1 0 0 1
PLT: platelets; plt: P PL PLT PLT: BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 :;:;:;:. 8 10 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 0 1 0 0
2523 2523 2523 2 25 252 2523 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 0 no 0 10 0 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 10 0 0 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 4 0 0 0 0 0
on the on o on on on BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (.)., 5 9 0 1 0 0 1
bilirubin values bilirubin b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 / 1 9 0 1 0 0 1
all three all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,- 3 9 0 1 0 0 1
tion, demonstrated tion, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,, 2 9 0 1 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
high burden high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 ,- 2 9 0 1 0 0 1
emia, predicted emia, e em emi emia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,--. 4 9 0 1 0 0 1
contrast, we contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
involvement and involvement i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
were not were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 3 0 1 0 0 1
HSCT is hsct H HS HSC HSCT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
In previous in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
without HSCT without w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (/-, 4 9 0 1 0 0 1
both harboring both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .; 2 9 0 1 0 0 1
60 pHLH 60 6 60 60 60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 -).- 4 9 0 1 0 0 1
edly, 15 edly, e ed edl edly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,() 3 9 0 1 0 0 1
a median a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 0 -. 2 9 0 1 0 0 1
Out of out O Ou Out Out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
to familial to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :- 2 9 0 1 0 0 1
ceived HLH-directed ceived c ce cei ceiv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -,- 3 9 0 1 0 0 1
ranging from ranging r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
CNS disease cns C CN CNS CNS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
patients responded patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
and remained and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 7 0 1 0 0 1
Overall, our overall, O Ov Ove Over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,, 2 9 0 1 0 0 1
over the over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
picture of picture p pi pic pict BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
come of come c co com come BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 8 0 1 0 0 1
acknowledge that acknowledge a ac ack ackn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,- 3 9 0 1 0 0 1
clude such clude c cl clu clud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
embraced during embraced e em emb embr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
have changed. have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 9 0 1 0 0 1
HLH-2004 has hlh-2004 H HL HLH HLH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 - 1 8 0 1 0 0 1
treatment results, treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
not result not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
tic investigation. tic t ti tic tic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 9 0 1 0 0 1
diagnostic criteria diagnostic d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 8 0 1 0 0 1
lected patients lected l le lec lect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
acknowledged that acknowledged a ac ack ackn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
mutations with mutations m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
the genetic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 1 0 0 1
tional studies tional t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 /(-). 5 10 0 1 0 0 1
These patients these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
therefore included therefore t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
note, we note, n no not note BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
or compound or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
pathogenicity is pathogenicity p pa pat path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 0 1 0 0 1
were alive were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 8 0 0 0 0 1
HLH and hlh H HL HLH HLH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 . 1 8 0 0 0 0 1
Although it although A Al Alt Alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
believe that believe b be bel beli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 9 0 0 0 0 1
management in management m ma man mana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 6 . 1 5 0 0 0 0 1
In conclusion, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
condition that condition c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 10 0 0 0 0 1
not rapidly not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 9 0 0 0 0 1
failing to failing f fa fai fail BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 - 1 9 0 0 0 0 1
remain at remain r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 0 0 0 1
usually present usually u us usu usua BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
and an and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 9 0 0 0 0 1
agents, appears agents, a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,. 2 9 0 0 0 0 1
control allowing control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
a higher a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 6 . 1 9 0 0 0 0 1
of patients of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 8 0 0 0 0 1
control after control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
from a from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,-, 3 8 0 0 0 0 1
by an by b by by by BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 -. 2 6 0 0 0 0 1
Disclosures Disclosures disclosures D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 3 0 0 0 0 1
No conflicts no N No No No BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 . 1 10 0 0 0 0 1
Contributions Contributions contributions C Co Con Cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 2 0 0 0 0 1
FP and fp F FP FP FP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 ., 2 9 0 0 0 0 1
AC, LB, ac, A AC AC, AC, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 ,,.,, 5 9 0 0 0 0 1
CM, VB, cm, C CM CM, CM, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 ,,,,,,,,,, 10 10 0 0 0 0 1
patients. AC, patients. p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 .,,. 4 9 0 0 0 0 1
performed the performed p pe per perf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 . 1 5 0 0 0 0 1
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 1 0 0 0 0 1
Part of part P Pa Par Part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 9 0 0 0 0 1
funded by funded f fu fun fund BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 () 2 10 0 0 0 0 1
O.N.L.U.S. O.N.L.U.S. o.n.l.u.s. O O. O.N O.N. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 ..... 5 1 0 0 0 0 1
Data-sharing statement data-sharing D Da Dat Data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 4 0 0 0 0 1
Data will data D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 10 0 0 0 0 1
responding author. responding r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 . 1 3 0 0 0 0 1
Appendix: AIEOP appendix: A Ap App Appe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 : 1 7 0 1 0 0 1
Antonino Trizzino antonino A An Ant Anto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 9 (),(), 6 9 0 1 0 0 1
Melchionda (Bologna), melchionda M Me Mel Melc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 (),(),- 7 9 0 1 0 0 1
icasa (Perugia), icasa i ic ica icas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 (),(), 6 9 0 1 0 0 1
(Modena), Daniela (modena), ( (M (Mo (Mod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 (),(),(- 8 9 0 1 0 0 1
este); Bernd este); e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 );(),(), 8 10 0 1 0 0 1
Vito Miraglia vito V Vi Vit Vito BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 9 (),(,) 6 9 0 1 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 1 0 0 1
1. Farquhar 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,. 3 8 0 1 0 0 1
reticulosis. Arch reticulosis. r re ret reti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 ..;():-. 8 7 0 1 0 0 1
2. Barbosa 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,. 5 10 0 1 0 0 1
the homologous the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 -. 2 8 0 1 0 0 1
Nature. 1996;382(6588):262-265. nature. N Na Nat Natu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 .;():-. 7 5 0 1 0 0 1
3. Coffey 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 .,,,. 5 10 0 1 0 0 1
EBV infection ebv E EB EBV EBV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 - 1 9 0 1 0 0 1
from mutations from f fr fro from BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 11 -.. 3 9 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 0 1 0 0
2524 2524 2524 2 25 252 2524 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 0 no 0 10 0 0 0 0 0
ARTICLE -Outcome article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 10 0 1 0 0 0
F. Pegoraro f. F F. F. F. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .. 2 4 0 1 0 0 0
1998;20(2):129-135. 1998;20(2):129-135. 1998;20(2):129-135. 1 19 199 1998 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 2 0 1 0 0 1
4. Nichols 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 10 0 1 0 0 1
an SH2 an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
syndrome. Proc syndrome. s sy syn synd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():-. 8 8 0 1 0 0 1
5. Sayos 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.-- 7 9 0 1 0 0 1
disease gene disease d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
the co-receptor the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -..;():-. 9 7 0 1 0 0 1
6. Stepp 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-,,. 6 9 0 1 0 0 1
defects in defects d de def defe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 8 0 1 0 0 1
Science. 1999;286(5446):1957-1959. science. S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .;():-. 7 5 0 1 0 0 1
7. Cetica 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
hemophagocytic lymphohistiocytosis: hemophagocytic h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 8 0 1 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .. 2 7 0 1 0 0 1
2016; 137(1):188-196. 2016; 2 20 201 2016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 3 0 1 0 0 1
8. Canna 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,. 3 6 0 1 0 0 1
lymphohistiocytosis. Blood. lymphohistiocytosis. l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():-. 8 7 0 1 0 0 1
9. Chinnici 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,, 6 9 0 1 0 0 1
C, et c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.. 3 8 0 1 0 0 1
Front Immunol. front F Fr Fro Fron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .;:. 4 4 0 1 0 0 1
10. Henter 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-,,. 6 9 0 1 0 0 1
hemophagocytic lymphohistiocytosis hemophagocytic h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 6 0 1 0 0 1
immunochemotherapy and immunochemotherapy i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 7 0 1 0 0 1
Blood. 2002;100(7):2367-2373. blood. B Bl Blo Bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .;():-. 7 4 0 1 0 0 1
11. Bergsten 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
etoposide and etoposide e et eto etop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :- 2 8 0 1 0 0 1
results of results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 -.. 3 7 0 1 0 0 1
2017;130(25):2728-2738. 2017;130(25):2728-2738. 2017;130(25):2728-2738. 2 20 201 2017 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 3 0 1 0 0 1
12. Mahlaoui 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-,,. 6 8 0 1 0 0 1
Immunotherapy of immunotherapy I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
with antithymocyte with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :- 2 8 0 1 0 0 1
report of report r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():-. 8 8 0 1 0 0 1
13. Marsh 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 8 0 1 0 0 1
refractory hemophagocytic refractory r re ref refr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 7 0 1 0 0 1
alemtuzumab. Pediatr alemtuzumab. a al ale alem BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():-. 8 7 0 1 0 0 1
14. Locatelli 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
with primary with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Med. 2020;382(19):1811-1822. med. M Me Med Med. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 4 0 1 0 0 1
15. Zhang 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.- 6 10 0 1 0 0 1
based stratified based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 8 0 1 0 0 1
lymphohistiocytosis. Blood. lymphohistiocytosis. l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..;():-. 8 7 0 1 0 0 1
16. Henter 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.-: 7 9 0 1 0 0 1
therapeutic guidelines therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 9 0 1 0 0 1
Pediatr Blood pediatr P Pe Ped Pedi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 6 0 1 0 0 1
17. World 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .. 2 8 0 1 0 0 1
Declaration of declaration D De Dec Decl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 : 1 9 0 1 0 0 1
involving human involving i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 8 0 1 0 0 1
18. Sieni 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
lymphohistiocytosis may lymphohistiocytosis l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 : 1 9 0 1 0 0 1
genetic features genetic g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():. 7 9 0 1 0 0 1
19. Beken 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
evaluation of evaluation e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
the importance the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 : 1 9 0 1 0 0 1
center experience. center c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 6 ..;():-. 8 8 0 1 0 0 1
20. Aricò 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 8 0 1 0 0 1
lymphohistiocytosis. Report lymphohistiocytosis. l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 . 1 7 0 1 0 0 1
International Registry. international I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Society. Leukemia. society. S So Soc Soci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 5 0 1 0 0 1
21. Trottestam 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
hemophagocytic lymphohistiocytosis: hemophagocytic h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 :- 2 8 0 1 0 0 1
HLH-94 treatment hlh-94 H HL HLH HLH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -..;():-. 9 8 0 1 0 0 1
22. Bayram 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 10 0 1 0 0 1
and long-term and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 7 0 1 0 0 1
hemophagocytic lymphohistiocytosis: hemophagocytic h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 :- 2 9 0 1 0 0 1
experience and experience e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Oncol. 2023;45(5):262-266. oncol. O On Onc Onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 3 0 1 0 0 1
23. Trottestam 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 10 0 1 0 0 1
death in death d de dea deat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Acta Paediatr. acta A Ac Act Acta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 5 0 1 0 0 1

